Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Platelet-rich Plasma on Blastocyst Formation in ICSI Cycles Involving Low-quality Sperm: A Randomised Study

NCT07579858 is registered in ClinicalTrials.gov with Stella Maris Women and Children Hospital as lead sponsor.

NCT NCT07579858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07579858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Platelet-rich Plasma on Blastocyst Formation in ICSI Cycles Involving Low-quality Sperm: A Randomised Study
Lead sponsor
Stella Maris Women and Children Hospital
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2023
Completion date
December 30, 2023
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blastocyst, blastocyst ivf, blastocyst quality, blastocysts, embryo development, embryo quality, embryologic parameters, platelet rich plasma, platelet rich plasma (prp), severe oligoasthenoteratozoospermia, sperm parameters in fertile and infertile men, sperm quality, spermatazoa disorders